MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)

• Status: Completed
• Trial end date: 2008-02-16
• Target enrollment: 0
• Participant gender: All

Summary

The clinical study compares safety and efficacy of MK0507A (dorzolamide 1.0% / timolol 0.5%) with 1) timolol 0.5% and with 2) concomitant therapy with dorzolamide 1.0% / timolol 0.5% in patients with glaucoma and ocular hypertension.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Dorzolamide; Maleic acid; Timolol

Criteria

Inclusion Criteria:

• Patients with glaucoma and ocular hypertension

Exclusion Criteria:

• History of ocular surgery within 3 months

• Administration contradiction to timolol and dorzolamide